Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene

被引:0
|
作者
Sinko, Gabriella [1 ]
Tompa, Marton [2 ,3 ]
Kiss, Zsuzsanna [4 ]
Kalman, Bernadette [2 ,5 ]
机构
[1] Markusovszky Univ, Dept Pediat, Teaching Hosp, Szombathely, Hungary
[2] Markusovszky Univ, Teaching Hosp, Ctr Mol Med, Szombathely, Hungary
[3] Szentagotha Res Ctr, Hungarian Ctr Genom & Bioinformat, Pecs, Hungary
[4] Markusovszky Univ, Dept Lab Med, Div Clin Genet, Teaching Hosp, Szombathely, Hungary
[5] Univ Pecs, Sch Med, Dept Lab Med, Pecs, Hungary
来源
关键词
vanishing white matter disease; whole exome sequencing; RATING-SCALE; HYPERINTENSITIES; MRI; DEMENTIA;
D O I
10.18071/isz.77.0207
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background - Leukodystrophies, a hete roge neous group of brain and spinal cord dis orders, often pose challenges in es tab li shing molecular etiology. Vanishing White Matter Disease (VWMD) is a rare sub type of leu kodys trophies presenting with characteristic clinical and MRI features, ne ver theless, achieving diag nostic certainty requires genetic studies. Case presentation - Our patient is a nine year old girl, who developed progressive gait difficulties at around 3-4 years of age. Her brain MRI showed confluent lesions with increased signal intensity in the cerebral and cerebellar white matter on T2/FLAIR se quen ces, within which hypointense regions ap peared with signal intensity resembling that of the cerebrospinal fluid on T1 sequences. Whole exome sequencing identified a homozygous likely pathogenic variant within the EIF2B5 gene in the proband, which was present in a heterozygous state in both asymptomatic parents. Having the clinical and molecular genetic diagnosis established, we explored therapeutic possibilities for the patient. Conclusion - VWMD is a severe form of leukodystrophies with little or no disease modifying therapy available until recently. A better understanding of its molecular pathogenesis offers some hope for new inventive therapies.
引用
收藏
页数:69
相关论文
共 50 条
  • [41] Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course
    Luisa Sambati
    Raffaele Agati
    Antonella Bacci
    Silvia Bianchi
    Sabina Capellari
    Neurological Sciences, 2013, 34 : 1235 - 1238
  • [42] Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease
    Ye Wu
    Yanxia Pan
    Li Du
    Jingmin Wang
    Qiang Gu
    Zhijie Gao
    Jie Li
    Xuerong Leng
    Jiong Qin
    Xiru Wu
    Yuwu Jiang
    Journal of Human Genetics, 2009, 54 : 74 - 77
  • [43] Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease
    Wu, Ye
    Pan, Yanxia
    Du, Li
    Wang, Jingmin
    Gu, Qiang
    Gao, Zhijie
    Li, Jie
    Leng, Xuerong
    Qin, Jiong
    Wu, Xiru
    Jiang, Yuwu
    JOURNAL OF HUMAN GENETICS, 2009, 54 (02) : 74 - 77
  • [44] Impaired eIF2B activity in oligodendrocytes contributes to vanishing white matter disease pathogenesis
    Lin, W.
    GLIA, 2017, 65 : E84 - E84
  • [45] Severity of Vanishing White Matter Disease Does Not Correlate with Deficits in eIF2B Activity or the Integrity of eIF2B Complexes
    Liu, Rui
    van der Lei, Hannemieke D. W.
    Wang, Xuemin
    Wortham, Noel C.
    Tang, Hua
    van Berkel, Carola G. M.
    Mufunde, Tsitsi Arikana
    Huang, Weida
    van der Knaap, Marjo S.
    Scheper, Gert C.
    Proud, Christopher G.
    HUMAN MUTATION, 2011, 32 (09) : 1036 - 1045
  • [46] A Rare Case of Vanishing White Matter Disease
    Thakur, Mrinali
    Pande, Vineeta
    Mane, Shailaja, V
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [47] An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease
    Shimada, Shino
    Miya, Kazushi
    Oda, Nozomi
    Watanabe, Yuki
    Kumada, Tomohiro
    Sugawara, Midori
    Shimojima, Keiko
    Yamamoto, Toshiyuki
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (07) : 1771 - 1777
  • [48] Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease
    Raini, Gali
    Sharet, Reut
    Herrero, Melisa
    Atzmon, Andrea
    Shenoy, Anjana
    Geiger, Tamar
    Elroy-Stein, Orna
    JOURNAL OF NEUROCHEMISTRY, 2017, 141 (05) : 694 - 707
  • [49] Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus
    Fogli, A
    Wong, KD
    Eymard-Pierre, E
    Wenger, J
    Bouffard, JP
    Goldin, E
    Black, DN
    Boespflug-Tanguy, O
    Schiffmann, R
    ANNALS OF NEUROLOGY, 2002, 52 (04) : 506 - 510
  • [50] A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation
    Fogli, A
    Dionisi-Vici, C
    Deodato, F
    Bartuli, A
    Boespflug-Tanguy, O
    Bertini, E
    NEUROLOGY, 2002, 59 (12) : 1966 - 1968